71. Shared genetic risk factors between cancer and cardiovascular diseasesAleksander Turk, Tanja Kunej, 2022, original scientific article Keywords: cancer, cardiovascular disease, risk factor, chemotherapy, comorbidity, genetic variant, interaction
network, cardio-oncology Full text (file, 3,26 MB) This document has more files! More... |
72. Early cost-effectiveness analysis of electrochemotherapy as a prospect treatment modality for skin melanomaEva Pirc, Carlo Federici, Maša Bošnjak, Barbara Perić, Matej Reberšek, Leandro Pecchia, Nebojša Glumac, Maja Čemažar, Marko Snoj, Gregor Serša, Damijan Miklavčič, 2020, original scientific article Keywords: skin cancer, melanoma, electrochemotherapy, electroporation, cost-effectiveness Full text (file, 1,22 MB) This document has more files! More... |
73. Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening settingAnja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, Mario Poljak, 2021, original scientific article Keywords: cervical cancer, human papillomavirus, screening, validation, alinity, cobas Full text (file, 410,13 KB) This document has more files! More... |
|
|
76. Nutritional status and health-related quality of life in men with advanced castrate-resistant prostate cancerLuka Čavka, Maja Pohar Perme, Branko Zakotnik, Nada Rotovnik-Kozjek, Boštjan Šeruga, 2022, original scientific article Keywords: prostate cancer, nutritional status, quality of life Full text (file, 1,36 MB) This document has more files! More... |
77. Tumour budding and poorly differentiated clusters in colon cancer – different manifestations of partial epithelial–mesenchymal transitionAna Pavlič, Emanuela Boštjančič, Rajko Kavalar, Bojan Ilijevec, Serena Bonin, Fabrizio Zanconati, Nina Zidar, 2022, original scientific article Keywords: colon cancer, colorectal cancer, epitheliall–mesenchymal transition, miRNA, partial epithelial–mesenchymal transition, poorly differentiated clusters, tumour budding Full text (file, 35,60 MB) This document has more files! More... |
78. Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapyAna Mitrović, Janja Završnik, Georgy Mikhaylov, Damijan Knez, Urša Pečar Fonović, Petra Matjan-Štefin, Miha Butinar, Stanislav Gobec, Boris Turk, Janko Kos, 2022, original scientific article Keywords: cathepsin X, cathepsin B, inhibitors, cancer, antitumor therapy, invasion Full text (file, 8,24 MB) This document has more files! More... |
79. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcomaŽiva Zajec, Jaka Dernovšek, Martin Distel, Martina Gobec, Tihomir Tomašič, 2023, original scientific article Keywords: cancer, Ewing sarcoma, Hsp90, inhibitor, molecular modelling Full text (file, 3,11 MB) This document has more files! More... |
80. New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicityAna Mitrović, Emanuela Senjor, Marko Jukič, Lara Bolčina, Mateja Prunk, Matic Proj, Milica Perišić, Stanislav Gobec, Janko Kos, 2022, original scientific article Keywords: cathepsin V, small-molecule inhibitors, antitumor therapy, cancer, cystatin F Full text (file, 3,84 MB) This document has more files! More... |